首頁 > 市場調查報告書 > 製藥

眼科藥物

美洲和歐洲眼藥水市場規模和預測（2021 - 2031）、全球和地區佔有率、趨勢和成長機會分析報告範圍：按藥物類別、應用、購買模式（處方藥和非處方藥）和地理位置（美國和歐洲）

市場調查報告書

商品編碼

1482327

美洲和歐洲眼藥水市場規模和預測（2021 - 2031）、全球和地區佔有率、趨勢和成長機會分析報告範圍：按藥物類別、應用、購買模式（處方藥和非處方藥）和地理位置（美國和歐洲）

America & Europe Eye Drops Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Drug Class, Application, Purchase Mode (Prescription and OTC), and Geography (America and Europe)

出版日期: 2024年05月03日 | 出版商:

The Insight Partners | 英文 150 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

美洲和歐洲眼藥水市場規模預計將從2023年的131.6億美元激增至2031年的198.8億美元；預計 2023 年至 2031 年市場複合年成長率為 5.3%。眼科疾病盛行率的上升和與年齡相關的眼疾的高發病率推動了美國和歐洲眼藥水市場的成長。

大多數患有眼睛問題的人都需要特殊的眼藥水。這些眼疾可以用眼藥水治療，效果更佳，痛苦也更小。使用這些產品可以有效治療乾眼、紅腫、疼痛、搔癢、青光眼、屈光不正、結膜炎、糖尿病黃斑水腫、老年黃斑部病變等症狀。滴眼液，也稱為人工淚液，是一類常用的治療藥物，透過滋潤眼睛並保護眼睛免受進一步感染來同時緩解乾眼和發炎的症狀。污染、生活方式的改變和長時間看螢幕是導致眼睛疼痛的主要原因。這些因素和環境條件推動了對具有緩解和保護作用的眼藥水的需求。無需處方即可購買多種眼藥水，這使得顧客更容易購買它們。

眼科疾病盛行率上升推動歐美眼藥水市場

糖尿病視網膜病變、青光眼、乾眼症（DED）等眼科疾病的發生率在各國尤其已開發國家人口中呈上升趨勢。 DED 會帶給患者不適、刺激和視力障礙。糖尿病視網膜病變代表微血管終末器官損傷。它從非增殖性糖尿病視網膜病變階段進展為增殖性糖尿病視網膜病變。隨著疾病的進展，相關的糖尿病黃斑水腫（DME）也可能變得明顯，導致視力問題和失明。根據《國家健康與保健調查》，截至2020 年4 月，美國約有1,640 萬人被檢測出患有乾眼症。 %。顯示，歐洲約有70 萬人患有DED。此外，根據歐洲國際糖尿病聯盟的數據，20-35% 的糖尿病患者有糖尿病視網膜病變的風險。在歐洲，1 型糖尿病患者的 DME 盛行率約為 8.8%。

白內障在老年人中非常常見，其特徵是在眼睛水晶體中形成混濁區域。根據 BMJ 發表的文章《全球白內障手術實踐模式：一項調查》，白內障摘除術是所有醫學專業中最常見的外科手術，估計美國每年有 370 萬例白內障手術，歐洲有 700 萬例白內障摘除術。根據歐盟統計局的數據，白內障手術是歐盟最常見的外科手術，2021 年進行了432 萬例手術。。

醫生通常會開眼藥水用於各種眼科疾病的治療、預防和術後護理。因此，眼科疾病的日益普及推動了美國和歐洲眼藥水市場的成長。

市場趨勢

生活方式的改變影響眼睛健康

生活方式因素會影響整體健康和福祉。人們每天在食物、健身、戶外活動等方面所做的選擇會影響他們的老化程度。老化過程也涉及眼睛健康和視力的變化。經常暴露在強烈的陽光下會增加眼部疾病的風險。根據美國眼科學會的數據，暴露在太陽紫外線下會增加黃斑部病變和白內障的風險。超重會透過多種方式增加眼部問題的風險。超重和肥胖會增加糖尿病的風險，從而導致糖尿病視網膜病變和青光眼等疾病導致視力喪失。此外，為改善生活品質而服用的非處方藥也會引起與處方藥類似的副作用。近年來乾眼症病例的迅速增加被認為是由於電腦使用增加而導致長時間接觸視覺顯示設備（VDT）所致。日常生活的許多方面都會對眼表和眼睛產生不可預見的影響。智慧型手機、筆記型電腦和電腦的使用增加是眼部疾病的主要危險因子之一。因此，這些疾病在整個生活方式疾病類別中佔有相當大的佔有率。因此，增加螢幕時間已成為現代生活方式的重要方面，這也是引發眼睛相關問題的原因。患有慢性眼部疾病和屈光不正的人患數字眼疲勞（DES）的風險更大。 DES 通常表現為不適、乾燥、視力模糊和頭痛。過度暴露於智慧型手機、平板電腦、iPad 和筆記型電腦螢幕發出的藍光也會導致嚴重的眼睛損傷。

在COVID-19大流行期間，所有公司都選擇採用在家工作（WFH）模式來控制疾病傳播。 WFH的成長趨勢增加了專業人士的螢幕時間，進一步加速了與眼睛相關的問題的數量。 Frontiers 發表的一項研究表明，由於過度的調適需求，連續使用數位裝置超過兩個小時會使用戶面臨發展 DES 的巨大風險。儘管COVID-19的傳播已在很大程度上得到控制，但許多公司仍允許員工繼續在家辦公，以減少整體支出。從長遠來看，這種生活方式的改變最終預計會對眼睛健康產生負面影響，從而在未來產生更大的眼藥水需求。

「美國和歐洲眼藥水市場」根據藥物類別、應用、購買模式和地理位置進行細分。

基於藥物類別的見解

依藥物類別，歐美眼藥水市場分為抗生素、人工淚液、類固醇等。抗生素細分市場在 2023 年佔據最大的市場佔有率。醫生會開抗生素眼藥水來治療抗菌感染。這些眼藥水的作用首先滲透到眼睛的多個組織層，然後再對感染起作用。在大多數情況下，抗生素眼藥水可以立即緩解病情。大多數抗生素眼藥水都是安全的且副作用最小。以眼藥水形式提供的不同抗生素包括氯黴素、紅黴素、阿奇黴素、環丙沙星、新黴素、莫西沙星、妥布黴素、桿菌肽、慶大霉素、多粘菌素B、加替沙星、貝西沙星和左氧氟沙星。除了功效之外，它們在糾正瞼板腺功能障礙方面的有益作用也有助於抗生素眼藥水市場的成長。

基於應用程式的見解

根據工藝，歐美眼藥水市場分為眼疾、眼部保健等。到 2023 年，眼科疾病領域佔據最大的市場佔有率。

美國食品藥物管理局、世界衛生組織、疾病管制與預防中心、聯合國人口活動基金和全球疾病負擔是在準備美國和歐洲的眼睛時參考的一些相關來源放棄市場研究報告。

The America & Europe eye drops market size is projected to surge from US$ 13.16 billion in 2023 to US$ 19.88 billion by 2031; the market is estimated to record a CAGR of 5.3% during 2023-2031. The rising prevalence of ophthalmic diseases and high incidence of age-related eye diseases propel the America & Europe eye drops market growth.

Most people who suffer from eye problems need special eye drops. These eye diseases can be treated with eye drops, which are more effective and less painful. Symptoms such as dry eye, redness, pain, itching, glaucoma, refractive error, conjunctivitis, diabetic macular edema, and age-related macular degeneration can be effectively treated using these products. Eye drops, also called artificial tears, are a class of therapeutics commonly used to simultaneously relieve the symptoms of dry and irritated eyes by moisturizing the eyes and protecting them from further infection. Pollution, changing lifestyles, and prolonged screen time are the prominent causes of eye pain. These factors and environmental conditions propel the demand for eye drops that provide relief and protection. The availability of a wide range of eye drops that can be purchased without a prescription has made it easier for customers to procure them.

Rising Prevalence of Ophthalmic Diseases Drives the America & Europe Eye Drops Market

The Incidence of ophthalmic diseases such as diabetic retinopathy, glaucoma, and dry eye disease (DED) is rising in the populations of various countries, especially the developed ones. DED causes discomfort, irritation, and visual disturbance in patients. Diabetic retinopathy represents microvascular end-organ damage. It progresses from non-proliferative diabetic retinopathy stages to proliferative diabetic retinopathy. As the disease progresses, associated diabetic macular edema (DME) may also become apparent, leading to vision problems and blindness. According to the "National Health and Wellness Survey," ~16.4 million people were detected with dry eye in the US as of April 2020. The study highlights an upsurge in prevalence by 2.7% among people aged 18-34 years during 2020. According to Novaliq GmbH, ~13 million Europeans and ~17 million Americans suffered from DED as of 2023. As per Santen Pharmaceuticals, nearly 11-30% of people in Europe suffered from DED in 2021. Data released on Medscape website states that ~700,000 people in the US suffer from proliferative diabetic retinopathy, with ~65,000 new cases recorded annually. Further, as per the International Diabetes Federation Europe, 20-35% of people with diabetes are at risk of developing diabetic retinopathy. The prevalence of DME in people with type 1 diabetes is approximately 8.8% in Europe.

Cataracts, which are highly common in elderly people, are characterized by the formation of a cloudy area in the eye lens. According to the article "Cataract surgery practice patterns worldwide: a survey," published in BMJ, cataract extraction is the most common surgical procedure in all medical specialties, with an estimated 3.7 million cases per year in the US and 7 million cases reported in Europe. As per Eurostat, cataract surgery was the most common surgical procedure in the EU, with 4.32 million operations in 2021. According to Santen Pharmaceuticals, the number of people suffering from glaucoma is estimated to soar up to ~7.85 million in Europe by 2040.

Doctors generally prescribe eye drops for the treatment, prevention, and post-surgical care of various ophthalmic diseases. Hence, the increasing prevalence of ophthalmic diseases fuels the America & Europe eye drops market growth.

Market Trend

Lifestyle Changes Affecting Eye Health

Lifestyle factors can impact the overall health and well-being. The choices made by people every day with regard to their food, fitness, outdoor activities, etc., affect how well they age. The aging process also involves changes in eye health and vision. Heavy sun exposure on a frequent basis can increase the risk of developing eye diseases. As per the American Academy of Ophthalmology, exposure to the sun's UV rays can increase the risk of macular degeneration and cataracts. Being overweight can increase the risk of eye problems in several ways. Overweight and obesity increase the risk of developing diabetes, which can lead to vision loss from diseases such as diabetic retinopathy and glaucoma. Further, non-prescription medications taken to improve quality of life can also cause side effects similar to those of prescription medications. The rapid increase in DED cases in recent years is believed to be due to prolonged exposure to visual display devices (VDT) caused by increasing computer use. Many aspects of everyday life can have unforeseen effects on the ocular surface and the eye. The increased use of smartphones, laptops, and computers is one of the key risk factors for eye diseases. Hence, these diseases hold a substantial share of the overall category of lifestyle diseases. Thus, increased screen time has become an important aspect of a modern lifestyle, which is responsible for triggering eye-related problems. Individuals with chronic eye conditions and refractive errors are at a greater risk of developing digital eye strain (DES). DES often manifests as discomfort, dryness, blurred vision, and headaches. Extreme exposure to blue rays emitted from smartphone, tablet, iPad, and laptop screens also causes serious eye damage.

During the COVID-19 pandemic, all companies opted to adopt the work-from-home (WFH) model to control the disease spread. The growing trend of WFH has intensified the screen time of working professionals, further accelerating the number of eye-related issues. According to a study published by Frontiers, the constant use of digital devices for more than two continuous hours puts users at a great risk of developing DES owing to the excessive accommodative demands. Although the spread of COVID-19 has been controlled to a large extent, many companies have allowed their employees to continue with WFH to decrease the overall expenditure. Such lifestyle changes are eventually expected to have negative effects on eye health in the long run, generating a greater demand for eye drops in the future.

The "America & Europe Eye Drops Market" is segmented on the basis of drug class, application, purchase mode, and geography.

Drug Class-Based Insights

Based on drug class, the America & Europe eye drops market is segmented into antibiotics, artificial tears, steroids, and others. The antibiotics segment held the largest market share in 2023. However, the steroids segment is anticipated to register the highest CAGR of 6.4% during the forecast period. Antibiotic eye drops are prescribed by doctors to treat antibacterial infections. The action of these eye drops starts with the penetration of multiple tissue layers of the eye before acting on the infection. In most cases, antibiotic eye drops provide immediate relief from the condition. Most antibiotic eye drops are safe and have minimal side effects. Different antibiotics that are offered in the form of eye drops include chloramphenicol, erythromycin, azithromycin, ciprofloxacin, neomycin, moxifloxacin, tobramycin, bacitracin, gentamycin, polymyxin B, gatifloxacin, besifloxacin, and levofloxacin. In addition to their efficacy, their beneficial role in rectifying the malfunctioning of meibomian glands contributes to the growth of the market for antibiotic eye drops.

Application-Based Insights

Based on process, the America & Europe eye drops market is segmented into eye diseases, eye care, and others. The eye diseases segment held the largest market share in 2023. However, the eye care segment is anticipated to register the highest CAGR during the forecast period.

US Food and Drug Administration, World Health Organization, Centers for Disease Control and Prevention, Centers for Disease Control and Prevention, United Nations Fund for Population Activities, and Global Burden of Disease are some of the relevant sources referred while preparing the America & Europe eye drops market research report.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. America and Europe Eye Drops Market Landscape

4.1 Overview
4.2 PEST Analysis

5. America and Europe Eye Drops Market - Key Market Dynamics

5.1 America and Europe Eye Drops Market - Key Market Dynamics
5.2 Market Drivers
- 5.2.1 Rising Prevalence of Ophthalmic Diseases
- 5.2.2 High Incidence of Age-Related Eye Diseases
5.3 Market Restraints
- 5.3.1 Rising Number of Product Recalls
5.4 Market Opportunities
- 5.4.1 Initiatives to Bolster Eye Care Awareness
5.5 Future Trends
- 5.5.1 Lifestyle Changes Affecting Eye Health
5.6 Impact:

6. America and Europe Eye Drops Market - Regional Market Analysis

6.1 America and Europe Eye Drops Market Revenue (US$ Million), 2023-2031

7. America and Europe Eye Drops Market Analysis - by Drug Class

7.1 Overview
7.2 Antibiotics
- 7.2.1 Overview
- 7.2.2 Antibiotics: America and Europe Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
7.3 Artificial Tears
- 7.3.1 Overview
- 7.3.2 Artificial Tears: America and Europe Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
7.4 Steroids
- 7.4.1 Overview
- 7.4.2 Steroids: America and Europe Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
7.5 Others
- 7.5.1 Overview
- 7.5.2 Others: America and Europe Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)

8. America and Europe Eye Drops Market Analysis - by Application

8.1 Overview
8.2 Eye Diseases
- 8.2.1 Overview
- 8.2.2 Eye Diseases: America and Europe Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
8.3 Eye Care
- 8.3.1 Overview
- 8.3.2 Eye Care: America and Europe Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
8.4 Others
- 8.4.1 Overview
- 8.4.2 Others: America and Europe Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)

9. America and Europe Eye Drops Market Analysis - by Purchase Mode

9.1 Overview
9.2 Prescription
- 9.2.1 Overview
- 9.2.2 Prescription: America and Europe Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
9.3 OTC
- 9.3.1 Overview
- 9.3.2 OTC: America and Europe Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)

10. America and Europe Eye Drops Market - Geographical Analysis

10.1 Overview
10.2 America
- 10.2.1 America Eye Drops Market Overview
- 10.2.2 America: America and Europe Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
  - 10.2.2.1 America: America and Europe Eye Drops Market - Revenue and Forecast Analysis - by Drug Class
    - 10.2.2.1.1 America: America and Europe Eye Drops Market - Revenue and Forecast Analysis - by Antibiotics
    - 10.2.2.1.2 America: America and Europe Eye Drops Market - Revenue and Forecast Analysis - by Artificial Tears
    - 10.2.2.1.3 America: America and Europe Eye Drops Market - Revenue and Forecast Analysis - by Steroids
  - 10.2.2.2 America: America and Europe Eye Drops Market - Revenue and Forecast Analysis - by Application
    - 10.2.2.2.1 America: America and Europe Eye Drops Market - Revenue and Forecast Analysis - by Eye Diseases
  - 10.2.2.3 America: America and Europe Eye Drops Market - Revenue and Forecast Analysis - by Purchase Mode
- 10.2.3 America: America and Europe Eye Drops Market - Revenue and Forecast Analysis - by Country
  - 10.2.3.1 United States: Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.2.3.1.1 Overview
    - 10.2.3.1.2 United States: America and Europe Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.2.3.1.3 United States: America and Europe Eye Drops Market Breakdown, by Drug Class
    - 10.2.3.1.3.1 United States: America and Europe Eye Drops Market Breakdown, by Antibiotics
    - 10.2.3.1.3.2 United States: America and Europe Eye Drops Market Breakdown, by Artificial Tears
    - 10.2.3.1.3.3 United States: America and Europe Eye Drops Market Breakdown, by Steroids
    - 10.2.3.1.4 United States: America and Europe Eye Drops Market Breakdown, by Application
    - 10.2.3.1.4.1 United States: America and Europe Eye Drops Market Breakdown, by Eye Diseases
    - 10.2.3.1.5 United States: America and Europe Eye Drops Market Breakdown, by Purchase Mode
  - 10.2.3.2 Canada: Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.2.3.2.1 Overview
    - 10.2.3.2.2 Canada: America and Europe Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.2.3.2.3 Canada: America and Europe Eye Drops Market Breakdown, by Drug Class
    - 10.2.3.2.3.1 Canada: America and Europe Eye Drops Market Breakdown, by Antibiotics
    - 10.2.3.2.3.2 Canada: America and Europe Eye Drops Market Breakdown, by Artificial Tears
    - 10.2.3.2.3.3 Canada: America and Europe Eye Drops Market Breakdown, by Steroids
    - 10.2.3.2.4 Canada: America and Europe Eye Drops Market Breakdown, by Application
    - 10.2.3.2.4.1 Canada: America and Europe Eye Drops Market Breakdown, by Eye Diseases
    - 10.2.3.2.5 Canada: America and Europe Eye Drops Market Breakdown, by Purchase Mode
  - 10.2.3.3 Brazil: Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.2.3.3.1 Overview
    - 10.2.3.3.2 Brazil: America and Europe Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.2.3.3.3 Brazil: America and Europe Eye Drops Market Breakdown, by Drug Class
    - 10.2.3.3.3.1 Brazil: America and Europe Eye Drops Market Breakdown, by Antibiotics
    - 10.2.3.3.3.2 Brazil: America and Europe Eye Drops Market Breakdown, by Artificial Tears
    - 10.2.3.3.3.3 Brazil: America and Europe Eye Drops Market Breakdown, by Steroids
    - 10.2.3.3.4 Brazil: America and Europe Eye Drops Market Breakdown, by Application
    - 10.2.3.3.4.1 Brazil: America and Europe Eye Drops Market Breakdown, by Eye Diseases
    - 10.2.3.3.5 Brazil: America and Europe Eye Drops Market Breakdown, by Purchase Mode
  - 10.2.3.4 Mexico: Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.2.3.4.1 Overview
    - 10.2.3.4.2 Mexico: America and Europe Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.2.3.4.3 Mexico: America and Europe Eye Drops Market Breakdown, by Drug Class
    - 10.2.3.4.3.1 Mexico: America and Europe Eye Drops Market Breakdown, by Antibiotics
    - 10.2.3.4.3.2 Mexico: America and Europe Eye Drops Market Breakdown, by Artificial Tears
    - 10.2.3.4.3.3 Mexico: America and Europe Eye Drops Market Breakdown, by Steroids
    - 10.2.3.4.4 Mexico: America and Europe Eye Drops Market Breakdown, by Application
    - 10.2.3.4.4.1 Mexico: America and Europe Eye Drops Market Breakdown, by Eye Diseases
    - 10.2.3.4.5 Mexico: America and Europe Eye Drops Market Breakdown, by Purchase Mode
  - 10.2.3.5 Argentina: Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.2.3.5.1 Overview
    - 10.2.3.5.2 Argentina: America and Europe Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.2.3.5.3 Argentina: America and Europe Eye Drops Market Breakdown, by Drug Class
    - 10.2.3.5.3.1 Argentina: America and Europe Eye Drops Market Breakdown, by Antibiotics
    - 10.2.3.5.3.2 Argentina: America and Europe Eye Drops Market Breakdown, by Artificial Tears
    - 10.2.3.5.3.3 Argentina: America and Europe Eye Drops Market Breakdown, by Steroids
    - 10.2.3.5.4 Argentina: America and Europe Eye Drops Market Breakdown, by Application
    - 10.2.3.5.4.1 Argentina: America and Europe Eye Drops Market Breakdown, by Eye Diseases
    - 10.2.3.5.5 Argentina: America and Europe Eye Drops Market Breakdown, by Purchase Mode
  - 10.2.3.6 Chile: Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.2.3.6.1 Overview
    - 10.2.3.6.2 Chile: America and Europe Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.2.3.6.3 Chile: America and Europe Eye Drops Market Breakdown, by Drug Class
    - 10.2.3.6.3.1 Chile: America and Europe Eye Drops Market Breakdown, by Antibiotics
    - 10.2.3.6.3.2 Chile: America and Europe Eye Drops Market Breakdown, by Artificial Tears
    - 10.2.3.6.3.3 Chile: America and Europe Eye Drops Market Breakdown, by Steroids
    - 10.2.3.6.4 Chile: America and Europe Eye Drops Market Breakdown, by Application
    - 10.2.3.6.4.1 Chile: America and Europe Eye Drops Market Breakdown, by Eye Diseases
    - 10.2.3.6.5 Chile: America and Europe Eye Drops Market Breakdown, by Purchase Mode
  - 10.2.3.7 Rest of America: Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.2.3.7.1 Overview
    - 10.2.3.7.2 Rest of America: America and Europe Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.2.3.7.3 Rest of America: America and Europe Eye Drops Market Breakdown, by Drug Class
    - 10.2.3.7.3.1 Rest of America: America and Europe Eye Drops Market Breakdown, by Antibiotics
    - 10.2.3.7.3.2 Rest of America: America and Europe Eye Drops Market Breakdown, by Artificial Tears
    - 10.2.3.7.3.3 Rest of America: America and Europe Eye Drops Market Breakdown, by Steroids
    - 10.2.3.7.4 Rest of America: America and Europe Eye Drops Market Breakdown, by Application
    - 10.2.3.7.4.1 Rest of America: America and Europe Eye Drops Market Breakdown, by Eye Diseases
    - 10.2.3.7.5 Rest of America: America and Europe Eye Drops Market Breakdown, by Purchase Mode
10.3 Europe
- 10.3.1 Overview
- 10.3.2 Europe: America and Europe Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
  - 10.3.2.1 Europe: America and Europe Eye Drops Market - Revenue and Forecast Analysis - by Drug Class
    - 10.3.2.1.1 Europe: America and Europe Eye Drops Market - Revenue and Forecast Analysis - by Antibiotics
    - 10.3.2.1.2 Europe: America and Europe Eye Drops Market - Revenue and Forecast Analysis - by Artificial Tears
    - 10.3.2.1.3 Europe: America and Europe Eye Drops Market - Revenue and Forecast Analysis - by Steroids
  - 10.3.2.2 Europe: America and Europe Eye Drops Market - Revenue and Forecast Analysis - by Application
    - 10.3.2.2.1 Europe: America and Europe Eye Drops Market - Revenue and Forecast Analysis - by Eye Diseases
  - 10.3.2.3 Europe: America and Europe Eye Drops Market - Revenue and Forecast Analysis - by Purchase Mode
- 10.3.3 Europe: America and Europe Eye Drops Market - Revenue and Forecast Analysis - by Country
  - 10.3.3.1 Germany: Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.3.3.1.1 Overview
    - 10.3.3.1.2 Germany: America and Europe Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.3.3.1.3 Germany: America and Europe Eye Drops Market Breakdown, by Drug Class
    - 10.3.3.1.3.1 Germany: America and Europe Eye Drops Market Breakdown, by Antibiotics
    - 10.3.3.1.3.2 Germany: America and Europe Eye Drops Market Breakdown, by Artificial Tears
    - 10.3.3.1.3.3 Germany: America and Europe Eye Drops Market Breakdown, by Steroids
    - 10.3.3.1.4 Germany: America and Europe Eye Drops Market Breakdown, by Application
    - 10.3.3.1.4.1 Germany: America and Europe Eye Drops Market Breakdown, by Eye Diseases
    - 10.3.3.1.5 Germany: America and Europe Eye Drops Market Breakdown, by Purchase Mode
  - 10.3.3.2 France: Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.3.3.2.1 Overview
    - 10.3.3.2.2 France: America and Europe Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.3.3.2.3 France: America and Europe Eye Drops Market Breakdown, by Drug Class
    - 10.3.3.2.3.1 France: America and Europe Eye Drops Market Breakdown, by Antibiotics
    - 10.3.3.2.3.2 France: America and Europe Eye Drops Market Breakdown, by Artificial Tears
    - 10.3.3.2.3.3 France: America and Europe Eye Drops Market Breakdown, by Steroids
    - 10.3.3.2.4 France: America and Europe Eye Drops Market Breakdown, by Application
    - 10.3.3.2.4.1 France: America and Europe Eye Drops Market Breakdown, by Eye Diseases
    - 10.3.3.2.5 France: America and Europe Eye Drops Market Breakdown, by Purchase Mode
  - 10.3.3.3 United Kingdom: Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.3.3.3.1 Overview
    - 10.3.3.3.2 United Kingdom: America and Europe Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.3.3.3.3 United Kingdom: America and Europe Eye Drops Market Breakdown, by Drug Class
    - 10.3.3.3.3.1 United Kingdom: America and Europe Eye Drops Market Breakdown, by Antibiotics
    - 10.3.3.3.3.2 United Kingdom: America and Europe Eye Drops Market Breakdown, by Artificial Tears
    - 10.3.3.3.3.3 United Kingdom: America and Europe Eye Drops Market Breakdown, by Steroids
    - 10.3.3.3.4 United Kingdom: America and Europe Eye Drops Market Breakdown, by Application
    - 10.3.3.3.4.1 United Kingdom: America and Europe Eye Drops Market Breakdown, by Eye Diseases
    - 10.3.3.3.5 United Kingdom: America and Europe Eye Drops Market Breakdown, by Purchase Mode
  - 10.3.3.4 Italy: Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.3.3.4.1 Overview
    - 10.3.3.4.2 Italy: America and Europe Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.3.3.4.3 Italy: America and Europe Eye Drops Market Breakdown, by Drug Class
    - 10.3.3.4.3.1 Italy: America and Europe Eye Drops Market Breakdown, by Antibiotics
    - 10.3.3.4.3.2 Italy: America and Europe Eye Drops Market Breakdown, by Artificial Tears
    - 10.3.3.4.3.3 Italy: America and Europe Eye Drops Market Breakdown, by Steroids
    - 10.3.3.4.4 Italy: America and Europe Eye Drops Market Breakdown, by Application
    - 10.3.3.4.4.1 Italy: America and Europe Eye Drops Market Breakdown, by Eye Diseases
    - 10.3.3.4.5 Italy: America and Europe Eye Drops Market Breakdown, by Purchase Mode
  - 10.3.3.5 Spain: Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.3.3.5.1 Overview
    - 10.3.3.5.2 Spain: America and Europe Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.3.3.5.3 Spain: America and Europe Eye Drops Market Breakdown, by Drug Class
    - 10.3.3.5.3.1 Spain: America and Europe Eye Drops Market Breakdown, by Antibiotics
    - 10.3.3.5.3.2 Spain: America and Europe Eye Drops Market Breakdown, by Artificial Tears
    - 10.3.3.5.3.3 Spain: America and Europe Eye Drops Market Breakdown, by Steroids
    - 10.3.3.5.4 Spain: America and Europe Eye Drops Market Breakdown, by Application
    - 10.3.3.5.4.1 Spain: America and Europe Eye Drops Market Breakdown, by Eye Diseases
    - 10.3.3.5.5 Spain: America and Europe Eye Drops Market Breakdown, by Purchase Mode
  - 10.3.3.6 Rest of Europe: Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.3.3.6.1 Overview
    - 10.3.3.6.2 Rest of Europe: America and Europe Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.3.3.6.3 Rest of Europe: America and Europe Eye Drops Market Breakdown, by Drug Class
    - 10.3.3.6.3.1 Rest of Europe: America and Europe Eye Drops Market Breakdown, by Antibiotics
    - 10.3.3.6.3.2 Rest of Europe: America and Europe Eye Drops Market Breakdown, by Artificial Tears
    - 10.3.3.6.3.3 Rest of Europe: America and Europe Eye Drops Market Breakdown, by Steroids
    - 10.3.3.6.4 Rest of Europe: America and Europe Eye Drops Market Breakdown, by Application
    - 10.3.3.6.4.1 Rest of Europe: America and Europe Eye Drops Market Breakdown, by Eye Diseases
    - 10.3.3.6.5 Rest of Europe: America and Europe Eye Drops Market Breakdown, by Purchase Mode

11. Industry Landscape

11.1 Overview
11.2 Growth Strategies in the America and Europe Eye Drops Market
11.3 Organic Growth Strategies
- 11.3.1 Overview
11.4 Inorganic Growth Strategies
- 11.4.1 Overview

12. Company Profiles

12.1 Alcon AG
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 AbbVie Inc
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Bausch & Lomb Inc
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Pfizer Inc
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Prestige Consumer Healthcare Inc.
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Similasan Corp
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Rohto Pharmaceutical Co Ltd
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Sager Pharma Kft
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Akorn Operating Company LLC
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 Santen Pharmaceutical Co., Ltd.
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments
12.11 SERVImed Industrial S.p.A.
- 12.11.1 Key Facts
- 12.11.2 Business Description
- 12.11.3 Products and Services
- 12.11.4 Financial Overview
- 12.11.5 SWOT Analysis
- 12.11.6 Key Developments
12.12 I-MED Pharma Inc.
- 12.12.1 Key Facts
- 12.12.2 Business Description
- 12.12.3 Products and Services
- 12.12.4 Financial Overview
- 12.12.5 SWOT Analysis
- 12.12.6 Key Developments

13. Appendix

13.1 About The Insight Partners

簡介目錄圖表

List Of Tables

Table 1. America and Europe Eye Drops Market Segmentation
Table 2. America: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 3. America: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Antibiotics
Table 4. America: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Artificial Tears
Table 5. America: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Steroids
Table 6. America: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 7. America: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Eye Diseases
Table 8. America: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Purchase Mode
Table 9. United States: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 10. United States: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Antibiotics
Table 11. United States: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Artificial Tears
Table 12. United States: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Steroids
Table 13. United States: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 14. United States: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Eye Diseases
Table 15. United States: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Purchase Mode
Table 16. Canada: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 17. Canada: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Antibiotics
Table 18. Canada: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Artificial Tears
Table 19. Canada: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Steroids
Table 20. Canada: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 21. Canada: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Eye Diseases
Table 22. Canada: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Purchase Mode
Table 23. Brazil: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 24. Brazil: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Antibiotics
Table 25. Brazil: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Artificial Tears
Table 26. Brazil: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Steroids
Table 27. Brazil: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 28. Brazil: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Eye Diseases
Table 29. Brazil: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Purchase Mode
Table 30. Mexico: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 31. Mexico: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Antibiotics
Table 32. Mexico: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Artificial Tears
Table 33. Mexico: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Steroids
Table 34. Mexico: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 35. Mexico: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Eye Diseases
Table 36. Mexico: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Purchase Mode
Table 37. Argentina: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 38. Argentina: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Antibiotics
Table 39. Argentina: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Artificial Tears
Table 40. Argentina: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Steroids
Table 41. Argentina: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 42. Argentina: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Eye Diseases
Table 43. Argentina: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Purchase Mode
Table 44. Chile: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 45. Chile: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Antibiotics
Table 46. Chile: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Artificial Tears
Table 47. Chile: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Steroids
Table 48. Chile: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 49. Chile: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Eye Diseases
Table 50. Chile: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Purchase Mode
Table 51. Rest of America: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 52. Rest of America: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Antibiotics
Table 53. Rest of America: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Artificial Tears
Table 54. Rest of America: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Steroids
Table 55. Rest of America: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 56. Rest of America: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Eye Diseases
Table 57. Rest of America: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Purchase Mode
Table 58. Europe: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 59. Europe: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Antibiotics
Table 60. Europe: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Artificial Tears
Table 61. Europe: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Steroids
Table 62. Europe: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 63. Europe: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Eye Diseases
Table 64. Europe: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Purchase Mode
Table 65. Germany: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 66. Germany: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Antibiotics
Table 67. Germany: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Artificial Tears
Table 68. Germany: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Steroids
Table 69. Germany: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 70. Germany: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Eye Diseases
Table 71. Germany: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Purchase Mode
Table 72. France: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 73. France: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Antibiotics
Table 74. France: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Artificial Tears
Table 75. France: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Steroids
Table 76. France: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 77. France: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Eye Diseases
Table 78. France: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Purchase Mode
Table 79. United Kingdom: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 80. United Kingdom: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Antibiotics
Table 81. United Kingdom: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Artificial Tears
Table 82. United Kingdom: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Steroids
Table 83. United Kingdom: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 84. United Kingdom: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Eye Diseases
Table 85. United Kingdom: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Purchase Mode
Table 86. Italy: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 87. Italy: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Antibiotics
Table 88. Italy: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Artificial Tears
Table 89. Italy: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Steroids
Table 90. Italy: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 91. Italy: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Eye Diseases
Table 92. Italy: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Purchase Mode
Table 93. Spain: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 94. Spain: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Antibiotics
Table 95. Spain: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Artificial Tears
Table 96. Spain: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Steroids
Table 97. Spain: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 98. Spain: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Eye Diseases
Table 99. Spain: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Purchase Mode
Table 100. Rest of Europe: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 101. Rest of Europe: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Antibiotics
Table 102. Rest of Europe: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Artificial Tears
Table 103. Rest of Europe: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Steroids
Table 104. Rest of Europe: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 105. Rest of Europe: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Eye Diseases
Table 106. Rest of Europe: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Purchase Mode
Table 107. Recent Organic Growth Strategies in the America and Europe Eye Drops Market
Table 108. Recent Inorganic Growth Strategies in the America and Europe Eye Drops Market

List Of Figures

Figure 1. America and Europe Eye Drops Market Segmentation, by Geography
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. America and Europe Eye Drops Market Revenue (US$ Million), 2023-2031
Figure 5. Eye Drops Market Breakdown by Geography, 2023 and 2031 (%)
Figure 6. America and Europe Eye Drops Market Share (%) - by Drug Class (2023 and 2031)
Figure 7. Antibiotics: America and Europe Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
Figure 8. Artificial Tears: America and Europe Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
Figure 9. Steroids: America and Europe Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
Figure 10. Others: America and Europe Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
Figure 11. America and Europe Eye Drops Market Share (%) - by Application (2023 and 2031)
Figure 12. Eye Diseases: America and Europe Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
Figure 13. Eye Care: America and Europe Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
Figure 14. Others: America and Europe Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
Figure 15. America and Europe Eye Drops Market Share (%) - by Purchase Mode (2023 and 2031)
Figure 16. Prescription: America and Europe Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
Figure 17. OTC: America and Europe Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
Figure 18. America and Europe Eye Drops Market Breakdown by Region, 2023 and 2031 (%)
Figure 19. America: Eye Drops Market, by Key Country - Revenue (2023) (US$ Million)
Figure 20. America: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million)
Figure 21. America: America and Europe Eye Drops Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 22. United States: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million)
Figure 23. Canada: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million)
Figure 24. Brazil: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million)
Figure 25. Mexico: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million)
Figure 26. Argentina: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million)
Figure 27. Chile: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million)
Figure 28. Rest of America: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million)
Figure 29. Europe: Eye Drops Market, by Key Country - Revenue (2023) (US$ Million)
Figure 30. Europe: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million)
Figure 31. Europe: America and Europe Eye Drops Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 32. Germany: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million)
Figure 33. France: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million)
Figure 34. United Kingdom: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million)
Figure 35. Italy: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million)
Figure 36. Spain: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million)
Figure 37. Rest of Europe: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million)
Figure 38. Growth Strategies in the America and Europe Eye Drops Market